Adult brain tumour research in 2024: Status, challenges and recommendations.
Loading...
Embargo End Date
ICR Authors
Authors
Purshouse, K
Bulbeck, HJ
Rooney, AG
Noble, KE
Carruthers, RD
Thompson, G
Hamerlik, P
Yap, C
Kurian, KM
Jefferies, SJ
Lopez, JS
Jenkinson, MD
Hanemann, CO
Stead, LF
Bulbeck, HJ
Rooney, AG
Noble, KE
Carruthers, RD
Thompson, G
Hamerlik, P
Yap, C
Kurian, KM
Jefferies, SJ
Lopez, JS
Jenkinson, MD
Hanemann, CO
Stead, LF
Document Type
Journal Article
Date
2024-04-01
Date Accepted
2024-03-25
Abstract
In 2015, a groundswell of brain tumour patient, carer and charity activism compelled the UK Minister for Life Sciences to form a brain tumour research task and finish group. This resulted, in 2018, with the UK government pledging £20m of funding, to be paralleled with £25m from Cancer Research UK, specifically for neuro-oncology research over the subsequent 5 years. Herein, we review if and how the adult brain tumour research landscape in the United Kingdom has changed over that time and what challenges and bottlenecks remain. We have identified seven universal brain tumour research priorities and three cross-cutting themes, which span the research spectrum from bench to bedside and back again. We discuss the status, challenges and recommendations for each one, specific to the United Kingdom.
Citation
Neuropathology and Applied Neurobiology, 2024, 50 (2), pp. e12979 -
Source Title
Neuropathology and Applied Neurobiology
Publisher
WILEY
ISSN
0305-1846
eISSN
1365-2990
1365-2990
1365-2990
Collections
Research Team
Early Phase Drug Develop